Publications

Found 4 results
Filters: Author is J.P. Meza-Espinoza  [Clear All Filters]
2012
R. Muñiz-Mendoza, Ayala-Madrigal, M. L., Partida-Pérez, M., Peregrina-Sandoval, J., Leal-Ugarte, E., Macias-Gomez, N., Peralta-Leal, V., Meza-Espinoza, J. P., Moreno-Ortiz, J. M., Ramírez-Ramírez, R., Suárez-Villanueva, S., and Gutierrez-Angulo, M., MLH1 and XRCC1 polymorphisms in Mexican patients with colorectal cancer, vol. 11, pp. 2315-2320, 2012.
Allan JM, Shorto J, Adlard J, Bury J, et al. (2008). MLH1 -93G>A promoter polymorphism and risk of mismatch repair deficient colorectal cancer. Int. J. Cancer 123: 2456-2459. http://dx.doi.org/10.1002/ijc.23770 PMid:18712731   Arita M, Zhong X, Min Z, Hemmi H, et al. (2003). Multiple sites required for expression in 5'-flanking region of the hMLH1 gene. Gene 306: 57-65. http://dx.doi.org/10.1016/S0378-1119(03)00385-8   Caldecott KW (2003). XRCC1 and DNA strand break repair. DNA Repair 2: 955-969. http://dx.doi.org/10.1016/S1568-7864(03)00118-6   Chen B, Zhou Y, Yang P and Wu XT (2012). Polymorphisms of XRCC1 and gastric cancer susceptibility: a meta-analysis. Mol. Biol. Rep. 39: 1305-1313. http://dx.doi.org/10.1007/s11033-011-0863-6 PMid:21604176   Gustincich S, Manfioletti G, Del SG, Schneider C, et al. (1991). A fast method for high-quality genomic DNA extraction from whole human blood. Biotechniques 11: 298-300, 302. PMid:1931026   Huang Y, Li L and Yu L (2009). XRCC1 Arg399Gln, Arg194Trp and Arg280His polymorphisms in breast cancer risk: a meta-analysis. Mutagenesis 24: 331-339. http://dx.doi.org/10.1093/mutage/gep013 PMid:19465687   Hung RJ, Hall J, Brennan P and Boffetta P (2005). Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am. J. Epidemiol. 162: 925-942. http://dx.doi.org/10.1093/aje/kwi318 PMid:16221808   Kim JC, Roh SA, Koo KH, Ka IH, et al. (2004). Genotyping possible polymorphic variants of human mismatch repair genes in healthy Korean individuals and sporadic colorectal cancer patients. Fam. Cancer 3: 129-137. http://dx.doi.org/10.1023/B:FAME.0000039919.66461.8f PMid:15340264   Markowitz SD and Bertagnolli MM (2009). Molecular origins of cancer: Molecular basis of colorectal cancer. N. Engl. J. Med. 361: 2449-2460. http://dx.doi.org/10.1056/NEJMra0804588 PMid:20018966 PMCid:2843693   Mei M, Liu D, Dong S, Ingvarsson S, et al. (2010). The MLH1 -93 promoter variant influences gene expression. Cancer Epidemiol. 34: 93-95. http://dx.doi.org/10.1016/j.canep.2009.12.009 PMid:20060799   Mei Q, Yan HL, Ding FX, Xue G, et al. (2006). Single-nucleotide polymorphisms of mismatch repair genes in healthy Chinese individuals and sporadic colorectal cancer patients. Cancer Genet. Cytogenet. 171: 17-23. http://dx.doi.org/10.1016/j.cancergencyto.2006.06.011 PMid:17074586   Meza-Espinoza JP, Peralta-Leal V, Gutierrez-Angulo M, Macias-Gomez N, et al. (2009). XRCC1 polymorphisms and haplotypes in Mexican patients with acute lymphoblastic leukemia. Genet. Mol. Res. 8: 1451-1458. http://dx.doi.org/10.4238/vol8-4gmr687 PMid:20013659   Nejda N, Iglesias D, Moreno AM, Medina A, V, et al. (2009). A MLH1 polymorphism that increases cancer risk is associated with better outcome in sporadic colorectal cancer. Cancer Genet. Cytogenet. 193: 71-77. http://dx.doi.org/10.1016/j.cancergencyto.2009.04.011 PMid:19665066   Pan XM, Yang WZ, Xu GH, Bai P, et al. (2011). The association between MLH1 -93 G>A polymorphism of DNA mismatch repair and cancer susceptibility: a meta-analysis. Mutagenesis 26: 667-673. http://dx.doi.org/10.1093/mutage/ger032 PMid:21745804   Perera S, Mrkonjic M, Rawson JB and Bapat B (2011). Functional effects of the MLH1-93G>A polymorphism on MLH1/ EPM2AIP1 promoter activity. Oncol. Rep. 25: 809-815. PMid:21206982   Raptis S, Mrkonjic M, Green RC, Pethe VV, et al. (2007). MLH1 -93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer. J. Natl. Cancer Inst. 99: 463-474. http://dx.doi.org/10.1093/jnci/djk095 PMid:17374836   Silva FC, Valentin MD, Ferreira FO, Carraro DM, et al. (2009). Mismatch repair genes in Lynch syndrome: a review. Sao Paulo Med. J. 127: 46-51. http://dx.doi.org/10.1590/S1516-31802009000100010 PMid:19466295   Takahashi M, Shimodaira H, Andreutti-Zaugg C, Iggo R, et al. (2007). Functional analysis of human MLH1 variants using yeast and in vitro mismatch repair assays. Cancer Res. 67: 4595-4604. http://dx.doi.org/10.1158/0008-5472.CAN-06-3509 PMid:17510385   Wang B, Wang D, Huang G, Zhang C, et al. (2010). XRCC1 polymorphisms and risk of colorectal cancer: a meta-analysis. Int. J. Colorectal Dis. 25: 313-321. http://dx.doi.org/10.1007/s00384-009-0866-0 PMid:20033188   Wei B, Zhou Y, Xu Z, Ruan J, et al. (2011). XRCC1 Arg399Gln and Arg194Trp polymorphisms in prostate cancer risk: a meta-analysis. Prostate Cancer Prostatic Dis. 14: 225-231. http://dx.doi.org/10.1038/pcan.2011.26 PMid:21647176   Zhang Z, Wan J, Jin X, Jin T, et al. (2005). Genetic polymorphisms in XRCC1, APE1, ADPRT, XRCC2, and XRCC3 and risk of chronic benzene poisoning in a Chinese occupational population. Cancer Epidemiol. Biomarkers Prev. 14: 2614-2619. http://dx.doi.org/10.1158/1055-9965.EPI-05-0143 PMid:16284386